These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 26120133

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Countering clinical inertia in lipid management: Expert workshop summary.
    Zullig LL, Egbuonu-Davis L, Trasy A, Oshotse C, Goldstein KM, Bosworth HB.
    Am Heart J; 2018 Dec; 206():24-29. PubMed ID: 30290290
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hypolipidemic drugs in elderly subjects: Indications and limits.
    Gazzola K, Vigna GB.
    Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1064-1070. PubMed ID: 27522161
    [Abstract] [Full Text] [Related]

  • 10. Landmark lipid-lowering trials in the primary prevention of cardiovascular disease.
    Chrispin J, Martin SS, Hasan RK, Joshi PH, Minder CM, McEvoy JW, Kohli P, Johnson AE, Wang L, Blaha MJ, Blumenthal RS.
    Clin Cardiol; 2013 Sep; 36(9):516-23. PubMed ID: 23722477
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance.
    Cooper A, O'Flynn N, Guideline Development Group.
    BMJ; 2008 May 31; 336(7655):1246-8. PubMed ID: 18511800
    [No Abstract] [Full Text] [Related]

  • 16. New ESC/EAS Guidelines for the management of dyslipidaemias - any controversies behind the consensus?
    Reiner Z.
    Eur J Cardiovasc Prev Rehabil; 2011 Oct 31; 18(5):724-7. PubMed ID: 21945917
    [No Abstract] [Full Text] [Related]

  • 17. Lipid management: maximising reduction of cardiac risk.
    Webb J, Gonna H, Ray KK.
    Clin Med (Lond); 2013 Dec 31; 13(6):618-20. PubMed ID: 24298114
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. News from ESC congress 2019: New ESC/EAS guidelines for dyslipidaemia management published.
    Stock J.
    Atherosclerosis; 2019 Dec 31; 291():124-126. PubMed ID: 31668350
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.